Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis

AIM: To evaluate the safety and efficacy of tenofovir disoproxil fumarate (TDF) as a first-line therapy in decompensated liver disease. METHODS: We enrolled 174 chronic hepatitis B-related liver cirrhosis patients treated with 300 mg/d TDF at six Korean centers. Of the 174 cirrhosis patients, 57 wer...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:World J Gastroenterol
Main Authors: Lee, Soon Kyu, Song, Myeong Jun, Kim, Seok Hyun, Lee, Byung Seok, Lee, Tae Hee, Kang, Young Woo, Kim, Suk Bae, Song, Il Han, Chae, Hee Bok, Ko, Soon Young, Lee, Jae Dong
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Inc 2017
Teme:
Observational Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5385406/
https://ncbi.nlm.nih.gov/pubmed/28428719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i13.2396
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki